Spyre Therapeutics (SYRE) executive compensation, 2026 proxy

Cameron Turtle, Chief Executive Officer, was paid $6.7M in 2025, down 4% from $7M the year before. The CEO-to-median-employee pay ratio was 15:1, on median employee pay of $437,242.

Filed
April 10, 2026
Annual meeting
May 27, 2026
Pay year
2025
Named executives
4
CEO total pay
$6.7M-4% vs prior year
CEO to median employee
15:1median $437,242
CEO pay in equity
90%$6M in awards
Prior say-on-pay support
93%of votes cast
CEO Total Compensation
$6,707,3612025 total compensation
CEO Base Salary
$665,000As of December 31, 2025
CEO Stock Option Awards
$5,552,886Grant date fair value
Median Employee Pay
$437,242Annual total compensation

How Turtle was paid

$6.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Cameron TurtleChief Executive Officer$6,707,361
Scott BurrowsChief Financial Officer$2,192,045
Sheldon SloanChief Medical Officer$2,211,805
Heidy King-JonesChief Legal Officer and Corporate Secretary$2,192,045

What changed and why

  • $6.7MChief Executive Officer Cameron Turtle received total compensation of $6,707,361 in fiscal year 2025.
  • $5.6MStock option awards for the CEO were valued at $5,552,886 in 2025.
  • 6.5%Base salary for the CEO increased by 6.5% to $665,000 for fiscal year 2025.
  • 93%Stockholders approved the previous say-on-pay proposal with approximately 93% support.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.